Could a monoclonal antibody treat peanut allergy?
Drug Discovery World
JUNE 26, 2023
IgGenix has made advances towards a peanut allergy therapeutic based on IgG4 monoclonal antibodies. The data shows that nearly all peanut-specific IgE antibodies discovered from peanut-allergic individuals were high affinity, with many exhibiting double-digit picomolar affinity. appeared first on Drug Discovery World (DDW).
Let's personalize your content